國立虎尾科技大學 |

Utilization of Detonation Nanodiamonds : = Nanocarrier for Gene Therapy in Non-Small Cell Lung Cancer.

Record Type:	Language materials, manuscript : Monograph/item
Title/Author:	Utilization of Detonation Nanodiamonds :/
Reminder of title:	Nanocarrier for Gene Therapy in Non-Small Cell Lung Cancer.
Author:	Gutierrez, Allan E.
Description:	1 online resource (36 pages)
Notes:	Source: Masters Abstracts International, Volume: 85-02.
Contained By:	Masters Abstracts International85-02.
Subject:	Pharmaceutical sciences. -
Online resource:	click for full text (PQDT)
ISBN:	9798379969066

Utilization of Detonation Nanodiamonds : = Nanocarrier for Gene Therapy in Non-Small Cell Lung Cancer.
Gutierrez, Allan E.

Utilization of Detonation Nanodiamonds :Nanocarrier for Gene Therapy in Non-Small Cell Lung Cancer. - 1 online resource (36 pages)

Source: Masters Abstracts International, Volume: 85-02.

Thesis (M.S.)--University of South Florida, 2023.

Includes bibliographical references

Lung cancer is one of the most prevalent and high mortality cancers in the world. Two different categories of lung cancer are non-small cell lung cancer which makes up 85% of cases, and small cell lung cancer which makes up the remaining 15% of cases. A significant risk factor that can lead to lung cancer is cigarette smoking (CS) however non-smoking cases i.e., secondhand CS, exposure to certain toxins and family history are on the rise. Both the main types of lung cancer have different system of stages, different ranges of treatment, and consequently low survival rates. Unfortunately, detection and confirmation usually are determined at stage four (IV) where the current treatments used are invasive with poor patient outcomes. Combined chemotherapy and radiation therapy are the primary treatment however have severe side effects as delivery of anticancer compounds to neoplastic tissue is important to limit toxicity as a result to targeting healthy cells. The demand for alternative treatment with minimal side effects is needed. Nanotechnology plays a role in enhancing efficient delivery of anticancer drug to the affected tissues by increasing the efficacy and reducing side effects. Presently, nanocarriers (NCs) have gained huge attention for their structural ability, good biocompatibility, and biodegradability. NCs fundamental goal is to tackle the delivery-related problems associated with standard chemo or radiation therapy and to carry medicines to the intended sites of action while avoiding undesirable side effects. Evidence suggest nanodiamonds (NDs) are potential new NCs for treatment for lung cancer. The objective of this study is to functionalize NDs as potential nano-drug carrier for gene therapy with minimized side effects and injury to health normal lung cells as well as to evaluate the functionalized properties of NDs as potential NCs for cancer gene therapy. We plan to purify commercial-graded NDs via acid wash and conduct functionalization studies utilizing Fourier transform infrared spectroscopy (FTIR). The A549, human epithelial cancer cell line will, be used to demonstrate NDs potential for safe and effective NCs that can be used for future gene therapy targeting the tumor microenvironment.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2024

Mode of access: World Wide Web

ISBN: 9798379969066Subjects--Topical Terms:

1180569
Pharmaceutical sciences.
Subjects--Index Terms:

Gene therapyIndex Terms--Genre/Form:

554714
Electronic books.

Utilization of Detonation Nanodiamonds : = Nanocarrier for Gene Therapy in Non-Small Cell Lung Cancer.
LDR:03610ntm a22003977 4500 001 1147431
005 20240918072807.5
006 m o d
007 cr bn ---uuuuu
008 250605s2023 xx obm 000 0 eng d
020 $a 9798379969066
035 $a (MiAaPQ)AAI30531136
035 $a AAI30531136
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Gutierrez, Allan E. $3 1473162
245 1 0 $a Utilization of Detonation Nanodiamonds : $b Nanocarrier for Gene Therapy in Non-Small Cell Lung Cancer.
264 0 $c 2023
300 $a 1 online resource (36 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Masters Abstracts International, Volume: 85-02.
500 $a Advisor: Allen-Gipson, Diane.
502 $a Thesis (M.S.)--University of South Florida, 2023.
504 $a Includes bibliographical references
520 $a Lung cancer is one of the most prevalent and high mortality cancers in the world. Two different categories of lung cancer are non-small cell lung cancer which makes up 85% of cases, and small cell lung cancer which makes up the remaining 15% of cases. A significant risk factor that can lead to lung cancer is cigarette smoking (CS) however non-smoking cases i.e., secondhand CS, exposure to certain toxins and family history are on the rise. Both the main types of lung cancer have different system of stages, different ranges of treatment, and consequently low survival rates. Unfortunately, detection and confirmation usually are determined at stage four (IV) where the current treatments used are invasive with poor patient outcomes. Combined chemotherapy and radiation therapy are the primary treatment however have severe side effects as delivery of anticancer compounds to neoplastic tissue is important to limit toxicity as a result to targeting healthy cells. The demand for alternative treatment with minimal side effects is needed. Nanotechnology plays a role in enhancing efficient delivery of anticancer drug to the affected tissues by increasing the efficacy and reducing side effects. Presently, nanocarriers (NCs) have gained huge attention for their structural ability, good biocompatibility, and biodegradability. NCs fundamental goal is to tackle the delivery-related problems associated with standard chemo or radiation therapy and to carry medicines to the intended sites of action while avoiding undesirable side effects. Evidence suggest nanodiamonds (NDs) are potential new NCs for treatment for lung cancer. The objective of this study is to functionalize NDs as potential nano-drug carrier for gene therapy with minimized side effects and injury to health normal lung cells as well as to evaluate the functionalized properties of NDs as potential NCs for cancer gene therapy. We plan to purify commercial-graded NDs via acid wash and conduct functionalization studies utilizing Fourier transform infrared spectroscopy (FTIR). The A549, human epithelial cancer cell line will, be used to demonstrate NDs potential for safe and effective NCs that can be used for future gene therapy targeting the tumor microenvironment.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2024
538 $a Mode of access: World Wide Web
650 4 $a Pharmaceutical sciences. $3 1180569
650 4 $a Oncology. $3 593951
650 4 $a Nanoscience. $3 632473
653 $a Gene therapy
653 $a Nanodiamonds
653 $a Cigarette smoking
653 $a Chemotherapy
653 $a Lung cancer
655 7 $a Electronic books. $2 local $3 554714
690 $a 0572
690 $a 0565
690 $a 0992
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a University of South Florida. $b Biology (Cell Biology, Microbiology, Molecular Biology). $3 1473163
773 0 $t Masters Abstracts International $g 85-02.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30531136 $z click for full text (PQDT)